TargetIsocitrate dehydrogenase [NADP] cytoplasmic(Homo sapiens (Human))
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataIC50: 0.25nMAssay Description:Inhibition of IDH1 R132H mutant in glioma patient-derived human TS603 neurosphere cells assessed as reduction in 2-HG content using alpha-ketoglutara...More data for this Ligand-Target Pair
TargetIsocitrate dehydrogenase [NADP] cytoplasmic(Homo sapiens (Human))
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataIC50: 0.300nMAssay Description:Inhibition of IDH1 R132H mutant in glioma patient-derived human TS603 neurosphere cells assessed as reduction in 2-HG content using alpha-ketoglutara...More data for this Ligand-Target Pair
TargetIsocitrate dehydrogenase [NADP] cytoplasmic(Homo sapiens (Human))
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataIC50: 0.700nMAssay Description:Inhibition of IDH1 R132H mutant in glioma patient-derived human TS603 neurosphere cells assessed as reduction in 2-HG content using alpha-ketoglutara...More data for this Ligand-Target Pair
TargetIsocitrate dehydrogenase [NADP] cytoplasmic(Homo sapiens (Human))
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataIC50: 1nMAssay Description:Inhibition of IDH1 R132H mutant in glioma patient-derived human TS603 neurosphere cells assessed as reduction in 2-HG content using alpha-ketoglutara...More data for this Ligand-Target Pair
TargetIsocitrate dehydrogenase [NADP] cytoplasmic(Homo sapiens (Human))
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataIC50: 1nMAssay Description:Inhibition of IDH1 R132H mutant in glioma patient-derived human TS603 neurosphere cells assessed as reduction in 2-HG content using alpha-ketoglutara...More data for this Ligand-Target Pair
Affinity DataIC50: 2nMAssay Description:Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into GST-ATF2 substrate preincubated for 20 mins before substrate addition measured a...More data for this Ligand-Target Pair
TargetIsocitrate dehydrogenase [NADP] cytoplasmic(Homo sapiens (Human))
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataIC50: 2nMAssay Description:Inhibition of IDH1 R132H mutant in glioma patient-derived human TS603 neurosphere cells assessed as reduction in 2-HG content using alpha-ketoglutara...More data for this Ligand-Target Pair
TargetIsocitrate dehydrogenase [NADP], mitochondrial(Homo sapiens (Human))
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataIC50: 3nMAssay Description:Inhibition of IDH2 R140Q mutant (unknown origin) transfected using lentiviral expression system in human U87MG cells assessed as reduction in 2-HG co...More data for this Ligand-Target Pair
TargetS-adenosylmethionine synthase isoform type-2(Human)
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataIC50: 4nMAssay Description:Inhibition of recombinant human MAT2A expressed in baculovirus infected Sf9 cells assessed as S-adenosyl methionine production using L-methionine as ...More data for this Ligand-Target Pair
TargetS-adenosylmethionine synthase isoform type-2(Human)
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataIC50: 4nMAssay Description:Inhibition of recombinant human MAT2A expressed in baculovirus infected Sf9 cells assessed as S-adenosyl methionine production using L-methionine as ...More data for this Ligand-Target Pair
TargetIsocitrate dehydrogenase [NADP] cytoplasmic(Homo sapiens (Human))
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataIC50: 4nMAssay Description:Inhibition of IDH1 R132H mutant in glioma patient-derived human TS603 neurosphere cells assessed as reduction in 2-HG content using alpha-ketoglutara...More data for this Ligand-Target Pair
TargetIsocitrate dehydrogenase [NADP] cytoplasmic(Homo sapiens (Human))
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataIC50: 4nMAssay Description:Inhibition of IDH1 R132H mutant in glioma patient-derived human TS603 neurosphere cells assessed as reduction in 2-HG content using alpha-ketoglutara...More data for this Ligand-Target Pair
TargetIsocitrate dehydrogenase [NADP], mitochondrial(Homo sapiens (Human))
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataIC50: 4nMAssay Description:Inhibition of IDH2 R140Q mutant (unknown origin) transfected using lentiviral expression system in human U87MG cells assessed as reduction in 2-HG co...More data for this Ligand-Target Pair
TargetS-adenosylmethionine synthase isoform type-2(Human)
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataIC50: 5nMAssay Description:Inhibition of recombinant human MAT2A expressed in baculovirus infected Sf9 cells assessed as S-adenosyl methionine production using L-methionine as ...More data for this Ligand-Target Pair
Affinity DataIC50: 6nMAssay Description:Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into GST-ATF2 substrate preincubated for 20 mins before substrate addition measured a...More data for this Ligand-Target Pair
TargetIsocitrate dehydrogenase [NADP], mitochondrial(Homo sapiens (Human))
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataIC50: 6nMAssay Description:Inhibition of IDH2 R140Q mutant (unknown origin) transfected using lentiviral expression system in human U87MG cells assessed as reduction in 2-HG co...More data for this Ligand-Target Pair
TargetS-adenosylmethionine synthase isoform type-2(Human)
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataIC50: 7nMAssay Description:Inhibition of recombinant human MAT2A expressed in baculovirus infected Sf9 cells assessed as S-adenosyl methionine production using L-methionine as ...More data for this Ligand-Target Pair
TargetS-adenosylmethionine synthase isoform type-2(Human)
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataIC50: 7nMAssay Description:Inhibition of recombinant human MAT2A expressed in baculovirus infected Sf9 cells assessed as S-adenosyl methionine production using L-methionine as ...More data for this Ligand-Target Pair
TargetIsocitrate dehydrogenase [NADP], mitochondrial(Homo sapiens (Human))
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataIC50: 7nMAssay Description:Inhibition of IDH2 R140Q mutant (unknown origin) transfected using lentiviral expression system in human U87MG cells assessed as reduction in 2-HG co...More data for this Ligand-Target Pair
TargetIsocitrate dehydrogenase [NADP] cytoplasmic(Homo sapiens (Human))
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataIC50: 7nMAssay Description:Inhibition of IDH1 R132H mutant in glioma patient-derived human TS603 neurosphere cells assessed as reduction in 2-HG content using alpha-ketoglutara...More data for this Ligand-Target Pair
TargetS-adenosylmethionine synthase isoform type-2(Human)
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataIC50: 7nMAssay Description:Inhibition of recombinant human MAT2A expressed in baculovirus infected Sf9 cells assessed as S-adenosyl methionine production using L-methionine as ...More data for this Ligand-Target Pair
TargetIsocitrate dehydrogenase [NADP], mitochondrial(Homo sapiens (Human))
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataIC50: 8nMAssay Description:Inhibition of IDH2 R140Q mutant (unknown origin) transfected using lentiviral expression system in human U87MG cells assessed as reduction in 2-HG co...More data for this Ligand-Target Pair
TargetS-adenosylmethionine synthase isoform type-2(Human)
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataIC50: 8nMAssay Description:Inhibition of recombinant human MAT2A expressed in baculovirus infected Sf9 cells assessed as S-adenosyl methionine production using L-methionine as ...More data for this Ligand-Target Pair
TargetIsocitrate dehydrogenase [NADP], mitochondrial(Homo sapiens (Human))
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataIC50: 9nMAssay Description:Inhibition of IDH2 R140Q mutant (unknown origin) transfected using lentiviral expression system in human U87MG cells assessed as reduction in 2-HG co...More data for this Ligand-Target Pair
TargetIsocitrate dehydrogenase [NADP], mitochondrial(Homo sapiens (Human))
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataIC50: 9nMAssay Description:Inhibition of full-length C-terminal His6 tagged IDH2 R140Q mutant (1 to 452 residues) (unknown origin) homodimer expressed in Sf9 cells assessed as ...More data for this Ligand-Target Pair
TargetIsocitrate dehydrogenase [NADP], mitochondrial(Homo sapiens (Human))
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataIC50: 9nMAssay Description:Inhibition of IDH2 R140Q mutant (unknown origin) transfected using lentiviral expression system in human U87MG cells assessed as reduction in 2-HG co...More data for this Ligand-Target Pair
TargetS-adenosylmethionine synthase isoform type-2(Human)
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataIC50: 10nMAssay Description:Inhibition of recombinant human MAT2A expressed in baculovirus infected Sf9 cells assessed as S-adenosyl methionine production using L-methionine as ...More data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:Inhibition of JNK2alpha2More data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into GST-ATF2 substrate preincubated for 20 mins before substrate addition measured a...More data for this Ligand-Target Pair
TargetS-adenosylmethionine synthase isoform type-2(Human)
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataIC50: 10nMAssay Description:Inhibition of MT2A in MTAP-null human HCT-116 cells after 72 hrs by LC-MS/MS analysisMore data for this Ligand-Target Pair
TargetS-adenosylmethionine synthase isoform type-2(Human)
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataIC50: 11nMAssay Description:Inhibition of MT2A in MTAP-null human HCT-116 cells after 72 hrs by LC-MS/MS analysisMore data for this Ligand-Target Pair
TargetS-adenosylmethionine synthase isoform type-2(Human)
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataIC50: 11nMAssay Description:Inhibition of recombinant human MAT2A expressed in baculovirus infected Sf9 cells assessed as S-adenosyl methionine production using L-methionine as ...More data for this Ligand-Target Pair
Affinity DataIC50: 12nMAssay Description:Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into GST-ATF2 substrate preincubated for 20 mins before substrate addition measured a...More data for this Ligand-Target Pair
Affinity DataIC50: 12nMAssay Description:Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into GST-ATF2 substrate preincubated for 20 mins before substrate addition measured a...More data for this Ligand-Target Pair
TargetS-adenosylmethionine synthase isoform type-2(Human)
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataIC50: 13nMAssay Description:Inhibition of recombinant human MAT2A expressed in baculovirus infected Sf9 cells assessed as S-adenosyl methionine production using L-methionine as ...More data for this Ligand-Target Pair
TargetS-adenosylmethionine synthase isoform type-2(Human)
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataIC50: 13nMAssay Description:Inhibition of MT2A in MTAP-null human HCT-116 cells after 72 hrs by LC-MS/MS analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 13nMAssay Description:Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into GST-ATF2 substrate preincubated for 20 mins before substrate addition measured a...More data for this Ligand-Target Pair
Affinity DataIC50: 13nMAssay Description:Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into GST-ATF2 substrate preincubated for 20 mins before substrate addition measured a...More data for this Ligand-Target Pair
TargetIsocitrate dehydrogenase [NADP], mitochondrial(Homo sapiens (Human))
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataIC50: 13nMAssay Description:Inhibition of full-length C-terminal His6 tagged IDH2 R140Q mutant (1 to 452 residues) (unknown origin) homodimer expressed in Sf9 cells assessed as ...More data for this Ligand-Target Pair
TargetS-adenosylmethionine synthase isoform type-2(Human)
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataIC50: 14nMAssay Description:Inhibition of recombinant human MAT2A expressed in baculovirus infected Sf9 cells assessed as S-adenosyl methionine production using L-methionine as ...More data for this Ligand-Target Pair
TargetS-adenosylmethionine synthase isoform type-2(Human)
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataIC50: 14nMAssay Description:Inhibition of MT2A in MTAP-null human HCT-116 cells after 72 hrs by LC-MS/MS analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 14nMAssay Description:Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into GST-ATF2 substrate preincubated for 20 mins before substrate addition measured a...More data for this Ligand-Target Pair
TargetIsocitrate dehydrogenase [NADP], mitochondrial(Homo sapiens (Human))
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataIC50: 14nMAssay Description:Inhibition of IDH2 R140Q mutant (unknown origin) transfected using lentiviral expression system in human U87MG cells assessed as reduction in 2-HG co...More data for this Ligand-Target Pair
TargetIsocitrate dehydrogenase [NADP], mitochondrial(Homo sapiens (Human))
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataIC50: 14nMAssay Description:Inhibition of IDH2 R140Q mutant (unknown origin) transfected using lentiviral expression system in human U87MG cells assessed as reduction in 2-HG co...More data for this Ligand-Target Pair
TargetIsocitrate dehydrogenase [NADP], mitochondrial(Homo sapiens (Human))
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Agios Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataIC50: 16nMAssay Description:Inhibition of full-length C-terminal His6 tagged IDH2 R140Q mutant (1 to 452 residues) (unknown origin) homodimer expressed in Sf9 cells assessed as ...More data for this Ligand-Target Pair
Affinity DataIC50: 18nMAssay Description:Inhibitory concentration towards binding of [125I]-glucagon to the human glucagon receptor expressed in CHO cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 18nMAssay Description:Inhibition of glucagon induced cAMP accumulation in human glucagon receptor transfected CHO cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 18nMAssay Description:Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into GST-ATF2 substrate preincubated for 20 mins before substrate addition measured a...More data for this Ligand-Target Pair
Affinity DataIC50: 18nMAssay Description:Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into GST-ATF2 substrate preincubated for 20 mins before substrate addition measured a...More data for this Ligand-Target Pair
